Literature DB >> 6941812

Increased translatable messenger ribonucleic acid for argininosuccinate synthetase in canavanine-resistant human cells.

T S Su, A L Beaudet, W E O'Brien.   

Abstract

The level of argininosuccinate synthetase activity in the human tissue culture cell line RPMI 2650 was 6-fold higher when citrulline was substituted for arginine in the culture medium. Canavanine-resistant (Canr) variants were isolated and had enzyme activity up to 25 nmol min-1 (mg of protein)-1 or 180-fold higher than that of the wild-type cells grown in arginine. The differences in enzyme activity were paralleled by differences in the amount of enzyme determined immunologically. The micrograms of enzyme per milligrams of protein, determined by complement fixation, were 0.03 for wild-type cells grown in arginine, 0.29 for wild-type cells grown in citrulline, and 6.73 for a Canr variant. In vivo labeling studies suggested increased synthesis of argininosuccinate synthetase in Canr cells, and in vitro translation of poly(adenylic acid) [poly(A)] messenger ribonucleic acid (mRNA) from wild-type and Canr cells confirmed a quantitatively compatible increase in translatable poly(A) mRNA for the enzyme in Canr cells. No precursor for the enzyme was recognized by using in vitro translation, and the poly(A) mRNA for the enzyme had a sedimentation value of 16 S by sucrose-gradient analysis. The levels of argininosuccinate synthetase activity in the Canr cells were similar to those found in normal liver.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6941812     DOI: 10.1021/bi00513a037

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Molecular definition of bovine argininosuccinate synthetase deficiency.

Authors:  J A Dennis; P J Healy; A L Beaudet; W E O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  N-acetylglutamate synthetase deficiency: clinical and laboratory observations.

Authors:  A L Pandya; R Koch; F A Hommes; J C Williams
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 3.  Amino acid regulation of gene expression.

Authors:  P Fafournoux; A Bruhat; C Jousse
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

4.  Induction of astrocyte argininosuccinate synthetase and argininosuccinate lyase by dibutyryl cyclic AMP and dexamethasone.

Authors:  M J Jackson; H R Zielke; C L Zielke
Journal:  Neurochem Res       Date:  1996-10       Impact factor: 3.996

5.  Cloning and sequence analysis of cDNA for human argininosuccinate lyase.

Authors:  W E O'Brien; R McInnes; K Kalumuck; M Adcock
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

Review 6.  Transcriptional regulation of genes for ornithine cycle enzymes.

Authors:  M Takiguchi; M Mori
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

7.  Molecular structure of the human argininosuccinate synthetase gene: occurrence of alternative mRNA splicing.

Authors:  S O Freytag; A L Beaudet; H G Bock; W E O'Brien
Journal:  Mol Cell Biol       Date:  1984-10       Impact factor: 4.272

8.  Sequence for human argininosuccinate synthetase cDNA.

Authors:  H G Bock; T S Su; W E O'Brien; A L Beaudet
Journal:  Nucleic Acids Res       Date:  1983-09-24       Impact factor: 16.971

9.  Human argininosuccinate synthetase minigenes are subject to arginine-mediated repression but not to trans induction.

Authors:  F M Boyce; G M Anderson; C D Rusk; S O Freytag
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

10.  Arginine-mediated regulation of an argininosuccinate synthetase minigene in normal and canavanine-resistant human cells.

Authors:  M J Jackson; W E O'Brien; A L Beaudet
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.